CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 24 January 2017 |
| Author/s |
author: Esperanza Martin-Sanchez |
| Publication date | January 24, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |